Your browser doesn't support javascript.
loading
Clinical and structural brain correlates of hypomimia in early-stage Parkinson's disease.
Sampedro, Frederic; Martínez-Horta, Saul; Horta-Barba, Andrea; Grothe, Michel J; Labrador-Espinosa, Miguel A; Jesús, Silvia; Adarmes-Gomez, Astrid; Carrillo, Fatima; Puig-Davi, Arnau; Roldan-Lora, Florinda; Aguilar-Barbera, Miquel; Pastor, Pau; Arroyo, Sonia Escalante; Vila, Berta Solano; Cots-Foraster, Anna; Ruiz-Martínez, Javier; Carrillo-Padilla, Francisco; Pueyo-Morlans, Mercedes; Gonzalez-Aramburu, Isabel; Infante-Ceberio, Jon; Hernandez-Vara, Jorge; de Fabregues-Boixar, Oriol; de Deus Fonticoba, Teresa; Avila, Asuncion; Martínez-Castrillo, Juan Carlos; Bejr-Kasem, Helena; Campolongo, Antonia; Pascual-Sedano, Berta; Martínez-Martín, Pablo; Santos-García, Diego; Mir, Pablo; Garcia-Ruiz, Pedro J; Kulisevsky, Jaime.
Afiliação
  • Sampedro F; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Martínez-Horta S; Unidad de Trastornos del Movimiento, Servicio de Neurología, Hospital de Sant Pau, Barcelona, Spain.
  • Horta-Barba A; Instituto de Investigacion del Hospital de Sant Pau, Barcelona, Spain.
  • Grothe MJ; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Labrador-Espinosa MA; Unidad de Trastornos del Movimiento, Servicio de Neurología, Hospital de Sant Pau, Barcelona, Spain.
  • Jesús S; Instituto de Investigacion del Hospital de Sant Pau, Barcelona, Spain.
  • Adarmes-Gomez A; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Carrillo F; Unidad de Trastornos del Movimiento, Servicio de Neurología, Hospital de Sant Pau, Barcelona, Spain.
  • Puig-Davi A; Instituto de Investigacion del Hospital de Sant Pau, Barcelona, Spain.
  • Roldan-Lora F; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Aguilar-Barbera M; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • Pastor P; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Arroyo SE; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • Vila BS; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Cots-Foraster A; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • Ruiz-Martínez J; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Carrillo-Padilla F; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • Pueyo-Morlans M; Movement Disorders Unit, Neurology Department, Hospital Universitario Virgen del Rocío, Seville, Spain.
  • Gonzalez-Aramburu I; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Infante-Ceberio J; Unidad de Trastornos del Movimiento, Servicio de Neurología, Hospital de Sant Pau, Barcelona, Spain.
  • Hernandez-Vara J; Instituto de Investigacion del Hospital de Sant Pau, Barcelona, Spain.
  • de Fabregues-Boixar O; Unidad de Radiodiagnostico, Hospital Universitario Virgen del Rocío, Seville, Spain.
  • de Deus Fonticoba T; Hospital Universitari Mutua de Terrassa, Terrassa, Barcelona, Spain.
  • Avila A; Hospital Universitari Mutua de Terrassa, Terrassa, Barcelona, Spain.
  • Martínez-Castrillo JC; Hospital de Tortosa Verge de la Cinta (HTVC), Tortosa, Tarragona, Spain.
  • Bejr-Kasem H; Institut Catala de la Salud (Girona), Institut d'Assistencia Sanitaria (IAS), Girona, Spain.
  • Campolongo A; Institut Catala de la Salud (Girona), Institut d'Assistencia Sanitaria (IAS), Girona, Spain.
  • Pascual-Sedano B; Instituto de Investigacion Biodonostia, Hospital Universitario Donostia, San Sebastian, Spain.
  • Martínez-Martín P; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
  • Santos-García D; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
  • Mir P; Unidad de Trastornos del Movimiento, Servicio de Neurología, Hospital Universitario Marques de Valdecilla, Santander, Spain.
  • Garcia-Ruiz PJ; Neurology Department and Neurodegenerative Diseases Research Group, Vall d'Hebron Universitary Campus, Barcelona, Spain.
  • Kulisevsky J; Neurology Department and Neurodegenerative Diseases Research Group, Vall d'Hebron Universitary Campus, Barcelona, Spain.
Eur J Neurol ; 29(12): 3720-3727, 2022 12.
Article em En | MEDLINE | ID: mdl-35852918
ABSTRACT
BACKGROUND AND

PURPOSE:

Reduced facial expression of emotions is a very frequent symptom of Parkinson's disease (PD) and has been considered part of the motor features of the disease. However, the neural correlates of hypomimia and the relationship between hypomimia and other non-motor symptoms of PD are poorly understood.

METHODS:

The clinical and structural brain correlates of hypomimia were studied. For this purpose, cross-sectional data from the COPPADIS study database were used. Age, disease duration, levodopa equivalent daily dose, Unified Parkinson's Disease Rating Scale part III (UPDRS-III), severity of apathy and depression and global cognitive status were collected. At the imaging level, analyses based on gray matter volume and cortical thickness were used.

RESULTS:

After controlling for multiple confounding variables such as age or disease duration, the severity of hypomimia was shown to be indissociable from the UPDRS-III speech and bradykinesia items and was significantly related to the severity of apathy (ß = 0.595; p < 0.0001). At the level of neural correlates, hypomimia was related to motor regions brodmann area 8 (BA 8) and to multiple fronto-temporo-parietal regions involved in the decoding, recognition and production of facial expression of emotions.

CONCLUSION:

Reduced facial expressivity in PD is related to the severity of symptoms of apathy and is mediated by the dysfunction of brain systems involved in motor control and in the recognition, integration and expression of emotions. Therefore, hypomimia in PD may be conceptualized not exclusively as a motor symptom but as a consequence of a multidimensional deficit leading to a symptom where motor and non-motor aspects converge.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Apatia Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Apatia Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article